Ketogenic Diet (KD) in Alcoholism
NCT03255031 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53
Last updated 2024-07-17
Summary
Background:
A ketogenic diet (KD) is high in fat and low in carbohydrates. Research has shown that a KD can lessen tremor in animals withdrawing from alcohol. KD can also help people who have difficulties with thinking, sleep, and mood. Researchers want to see if KD can lessen symptoms of alcohol withdrawal in people with alcohol use disorder.
Objective:
To test the effects of a ketogenic diet on alcohol withdrawal symptoms.
Eligibility:
Adults 18 years or older who are moderate or severe alcohol drinkers and are seeking treatment for alcohol use. They must be in the NIAAA inpatient alcohol treatment program.
Design:
Participants will be screened under another protocol. They will have a medical and psychiatric history, physical exam, and blood and urine tests. Participants will have a breath test for alcohol.
The study will be done in a 3-week stay in the clinic.
Participants will get either a KD or Standard American diet.
Participants will have breathalyzer, blood, and urine tests.
Participants will have magnetic resonance imaging (MRI) scans. The scanner is a cylinder in a magnetic field. They will lie on a table that slides in and out of the cylinder. They will do tasks on a computer during the scan.
Participants will have tests of thinking, memory, and attention.
Participants will have their sleeping and waking measured. They will wear a device like a headband held in place with elastic straps. Several electrodes will be placed on the body.
Participants will have heart tests.
Participants will wear an activity monitor on the wrist.
After the clinic stay, participants will be called by phone about 5 times over 3 months.
Conditions
- Alcoholism
Interventions
- OTHER
-
Ketogenic Diet (KD)
For each meal at breakfast, lunch and dinner, the diets will consist of ketogenic diet (KD) meal. Compliance tests are done twice a week with a blood test measuring ketone levels.
- OTHER
-
Standard American (SA) Meals and Shakes
For each meal at breakfast, lunch and dinner, the diets will consist of SA meal (carbohydrate rich) KD meal. Compliance tests are done twice a week with a blood test measuring ketone levels.
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
lead NIH
Principal Investigators
-
Gene-Jack Wang, M.D. · National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-24
- Primary Completion
- 2020-05-12
- Completion
- 2023-02-07
Countries
- United States
Study Locations
More Related Trials
-
Ketamine for Reduction of Alcoholic Relapse
NCT02649231 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
NCT06173973 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal
NCT04205682 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
NCT05015881 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients
NCT00758277 ·Status: COMPLETED ·Phase: PHASE3
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
Ketamine Alcohol (in Treatment-Resistant Depression)
NCT02122562 ·Status: RECRUITING ·Phase: PHASE2
-
Hangover, Congeners, Sleep and Occupational Performance
NCT00247585 ·Status: COMPLETED ·Phase: PHASE2
-
1-Octanol to Treat Essential Tremor
NCT00016679 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Exploratory Plasmatic Markers of Alcohol Withdrawal
NCT05216705 ·Status: COMPLETED
-
Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence
NCT01014533 ·Status: COMPLETED ·Phase: NA
-
Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study
NCT00769158 ·Status: COMPLETED ·Phase: PHASE1
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
NCT02885311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ethanol Response in Essential Tremor: Clinical and Neurophysiological Correlates
NCT01200966 ·Status: COMPLETED
-
Ketamine for Depression and Alcohol Dependence
NCT01551329 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine for the Treatment for Alcohol Use Disorder in the ED
NCT05661669 ·Status: WITHDRAWN ·Phase: PHASE2
-
Semaglutide for Alcohol Use Disorder
NCT05520775 ·Status: COMPLETED ·Phase: PHASE2
-
Deep Brain Stimulation for Refractory Alcoholism
NCT01798888 ·Status: WITHDRAWN ·Phase: PHASE1
-
Alcohol Detoxification in Primary Care Treatment (ADEPT)
NCT00855699 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Naltrexone on Alcohol Craving and on Brain Activity During Alcohol Infusion
NCT00667771 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effects of Levetiracetam on Alcohol Dependent Subjects
NCT00325182 ·Status: COMPLETED ·Phase: PHASE4
-
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
NCT01625611 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-responsive Essential Tremor
NCT00102596 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Cannabidiol in Alcohol Use Disorder
NCT03252756 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cognitive Retraining and Brain Stimulation for Alcohol Use
NCT02045108 ·Status: COMPLETED ·Phase: NA